HOME >> BIOLOGY >> NEWS
Targeting a key enzyme with gene therapy reversed course of Alzheimer's disease in mouse models

In mice, that had been genetically engineered to develop Alzheimer's disease, scientists were able to reverse the rodents' memory loss by reducing the amount of an enzyme that is crucial for the development of Alzheimer's disease.

"What we are showing is a proof of principle that stopping the synthesis of a protein that is necessary for the formation of the telltale plaques reverses the progression of the disease, and more importantly, the cognitive function of these mice, which had already been impaired, has now recovered," says Inder Verma, professor in the Laboratory for Genetics at the Salk Institute for Biological Studies.

The findings, which are the result of a close collaboration between researchers at the Salk Institute and scientists at the University of California in San Diego, are reported in an advance on-line publication of Nature Neuroscience.

In the past, gene therapy has been mainly used to deliver normal genes into cells to compensate for defective versions of the gene causing disease. In their study, the researchers used gene therapy to silence a normally functioning gene. Exploiting a mechanism called RNA interference, they were able to turn down the gene that helps produce the characteristic amyloid plaques that are one of the hallmarks of Alzheimer's disease.

"Within a month of treatment, mice that had already suffered memory deficits could learn and remember how to find their way through a water maze," says co-author Robert Marr, a post-doctoral researcher in Verma's lab.

"It appears that these mice can come back from a very severe level of disease progression," adds first author Oded Singer, also at the Salk. "This is a very important finding because humans are usually diagnosed when the disease has already progressed relatively far."

But he warns that it is too early to make direct comparisons with the human disease, since mice ordinarily don't develop the symptoms of the disease unless they are
'"/>

Contact: Cathy Yarbrough
yarbrough@salk.edu
858-453-4100 x 1290
Salk Institute
20-Sep-2005


Page: 1 2 3

Related biology news :

1. Targeting key proteins of carcinogenesis
2. Targeting tumors the natural way
3. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
4. Targeting tau: Inflammation study suggests new approach for fighting Alzheimers
5. Best of both worlds -- Targeting a single gene could inhibit bone decay and stimulate bone growth
6. Targeting wolbachia, doxycycline reduces pathology of lymphatic filariasis
7. Targeting lung cancer
8. Targeting the dosage compensation complex
9. Targeting pancreatic cancer
10. Targeting tumor growth
11. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/15/2016)... Yissum Research Development Company of the ... the Hebrew University, announced today the formation of ... various human biological indicators. Neteera Technologies has completed its ... investors. ... electromagnetic emissions from sweat ducts, enables reliable and speedy ...
(Date:3/10/2016)... -- --> --> ... Access Management Market by Component (Provisioning, Directory Services, Password ... Size, by Deployment, by Vertical, and by Region - ... is estimated to grow from USD 7.20 Billion in ... Compound Annual Growth Rate (CAGR) of 12.2% during the ...
(Date:3/8/2016)... N.C. , March 8, 2016   ... sensor technology, today announced it has secured $11M ... by GII Tech, a new venture fund being ... with additional participation from existing investors TDF Ventures ... the funds to continue its triple-digit growth and ...
Breaking Biology News(10 mins):
(Date:5/6/2016)... AUSTIN, Texas , May 6, 2016 ... risk drug addiction from prescription pain medication when treating ... in adult stem cell therapy, doctors can go right ... potentially dangerous drugs. MedRebels, an educational organization, provides physician ... therapy and a search feature to find physicians across ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The ... to identify individuals at increased risk for the development of chronic pain, which ...
(Date:5/5/2016)... ... May 05, 2016 , ... ProMIS ... of its first three targets, it has identified a fourth in a series ... in the development and progression of Alzheimer’s disease (AD). , “This ...
(Date:5/4/2016)... ... May 04, 2016 , ... Proove Biosciences, Inc. , the ... partnership with McGill University . The partnership is designed to advance research in ... to help patients in pain. With the new agreement, researchers at Proove Biosciences are ...
Breaking Biology Technology:
Cached News: